This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Equine Symmetric Dimethylarginine (SDMA) ELISA Kit-Competitive
Product Overview
BioVenic Equine Symmetric Dimethylarginine (SDMA) ELISA Kit-Competitive is designed for the quantitative determination of Equine SDMA in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
In equine medicine, SDMA is a crucial biomarker for early renal dysfunction. It is produced by the post-translational methylation of arginine residues by protein arginine methyltransferases (PRMTs) and released into the blood during protein degradation. Because SDMA is primarily eliminated via glomerular filtration, elevated serum levels serve as a reliable indicator of a decreased Glomerular Filtration Rate (GFR). Unlike creatinine, equine SDMA remains unaffected by the horse's significant muscle mass or high-protein exercise diets, allowing for earlier detection of kidney injury.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.